HOWARD I. SCHER is the Chief of the Genitourinary Oncology at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College. He has a depth of experience in clinical trials for novel types of cancer treatment.[1]


Early life and education

Scher earned his BS from Bates College and his MD from New York University School of Medicine before doing his residency at Bellevue Hospital.[2] He married Deborah Ann Lafer in 1989.[3]


Career

Scher has been an investigator at Memorial Sloan Kettering Cancer Center since 1992 and Professor of Medicine at the Weill Cornell Medical College.[4] His areas of research include PI3K, the androgen receptor, HSP90, and immunotherapy.

Scher is on the board of directors at Asterias, a biotechnology company.[5]

Scher was awarded American Association for Cancer Research's 2015 Team Science Award along with Michael E. Jung and Charles Sawyers for their work in the development of enzalutamide.[6] He has also collaborated with Brett Carver and Neal Rosen, both also at MSKCC, on experimental cancer therapeutics for androgen-resistance prostate cancer.[7]

Scher has published over 500 scholarly works.


References

Category:Year of birth missing (living people) Category:Living people Category:American oncologists Category:Bates College alumni Category:New York University School of Medicine alumni

[1]

[2]

[3]

[4]

[5]

[6]

[7]